ESLA Estrella Immunopharma, Inc.
Nasdaq · SEC CIK 1844417 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 7 since 2022-03-17, latest 2026-08-26 19:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Liu Cheng | CEO, Dir | — | — |
| Xu Jiandong | CFO | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-26 19:23 | 2026-08-25 | ESLA | Liu Cheng | CEO, Dir | M - OptEx | $0.815 | +100.0K | 397.4K | +34% | +$81.5K |
| D | 2026-08-25 21:55 | 2026-08-18 | ESLA | Xu Jiandong | CFO | M - OptEx | $0.815 | +100.0K | 365.5K | +38% | +$81.5K |
| M | 2026-04-29 21:36 | 2025-09-11+ | ESLA | Xu Jiandong | CFO | P - Purchase | $1.30 | +1,100 | 265.5K | +0.4% | +$1,434 |
| I | 2026-04-29 21:36 | 2025-09-22 | ESLA | Xu Jiandong | CFO | P - Purchase | $1.16 | +1,000 | 16.7K | +6% | +$1,160 |
| I | 2023-10-05 | 2023-09-29 | ESLA | ALTMAN JEFFREY A | 10% | J - Other | $10.86 | -255.0K | 0 | -100% | -$2.77M |
| E | 2022-03-17 | 2022-03-04 | ESLA | Li Jianwei | Co-CEO, Dir, 10% | P - Purchase | $314,700.00 | +142.0K | 1.25M | +13% | — |
Purchase Sale Sale after option exercise All abbreviations